# Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH

> **NCT01155141** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 15 (actual)

## Conditions studied

- Kidney Diseases

## Interventions

- **DRUG:** H.P. Acthar Gel

## Key facts

- **NCT ID:** NCT01155141
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01155141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01155141, "Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01155141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*